期刊文献+

PPARγ在肝外胆管癌中的表达及其意义 被引量:1

下载PDF
导出
摘要 目的观察PPARγ mRNA和蛋白在肝外胆管癌组织中的表达,并探讨其与肝外胆管癌临床病理特征之间的关系。方法采用RTPCR和Western印迹检测PPARγ mRNA和蛋白在30例肝外胆管癌组织中的表达情况。结果RT-PCR法检测结果显示肝外胆管癌组织中,淋巴结转移组和无淋巴结转移组PPARγ mRNA表达分别为0.47±0.06和0.24±0.07,差异有统计学意义(P<0.01);低分化组和高中分化组PPARγ mR-NA表达分别为0.3±0.19和0.17±0.01,差异无统计学意义(P>0.05);Ⅱ、Ⅲ期和Ⅰ期肝外胆管癌组织PPARγ mRNA表达分别为0.63±0.35和0.63±0.28,差异无统计学意义(P>0.05)。Western印迹结果显示肝外胆管癌组织中,淋巴结转移组和无淋巴结转移组PPARγ蛋白表达水平分别为2.0±0.44和0.93±0.21,差异有统计学意义(P<0.01);低分化组和高中分化组中,PPARγ蛋白表达分别为0.87±0.23和0.96±0.15,差异无统计学意义(P>0.05)。Ⅱ、Ⅲ期和Ⅰ期,PPARγ蛋白表达分别为2.45±0.54和1.95±0.24,两组差异无统计学意义(P>0.05)。结论PPARγ可能对肝外胆管癌的发生和发展起促进作用。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第4期450-452,共3页 Chinese Journal of Gerontology
基金 河北省卫生厅医学科学研究重点课题计划指令性项目(08141)
  • 相关文献

参考文献10

  • 1程文,程南生,熊先泽,夏庆杰,陈清英,闫乃红.过氧化物酶体增殖物激活受体γ在肝门部胆管癌中的表达及其配体对胆管癌细胞生长的抑制作用[J].中华实验外科杂志,2005,22(11):1406-1406. 被引量:7
  • 2Yeshizawa K,Cioca DP,Kawa S,et al. Peroxisome proliferator-activated re- ceptor gamma ligand troglitazone induces cell cycle arrest and apoptesis of hepatocellular carcinoma cell lines [J]. Cancer,2002 ;95 ( 10 ) : 2243 -51.
  • 3Yoshida K,Tauabe K, Fujii D, et al. Induction mechanism of apoptosis by troglitazone through peroxisome prolife rator-activated receptor-gamma in gastric carcinoma cells[J]. Antieancer Res,2003 ;23 ( 1 A ) :267-73.
  • 4Kitamura S, Miyazaki Y, Shinomura Y,et al. Peroxisome proliferator activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells[J].Jpn J Res, 1999 ;90( 1 ) :75-80.
  • 5Itam IA, Watanabe G, Shimada Y,et al. Ligands for peroxisome proliferator activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo [J].Int J Cancer,2001 ;94 (3) :370-6.
  • 6Han C, Demetris AJ, Michalopoulos GK, et al. PPAR-γ ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21WAF1/Cipl pathway[ J]. Hepatology,2003 ;38 ( 1 ) : 167-77.
  • 7程文,程南生,熊先泽,夏庆杰,陈清英,闫乃红,敬静.PPAR-γ在肝门部胆管癌中的表达及其配体激活后对胆管癌细胞的作用[J].四川大学学报(医学版),2006,37(5):745-749. 被引量:4
  • 8DuBois RN ,Gupta R,Brockman J ,et al. The nuclear ercosanoid receptor, PPARs, is aberrantly expressed in cilonic cancers[ J]. Carcinogenesis, 1998 ;19( 1 ) :49-53.
  • 9Zhang GY, Ahmed N, Riley C, et al. Enhanced expression of peroxisome proliferators -activated receptor gamma in epithelial ovarian carcinoma [J].Br J Cancer,2005 ;92 ( 1 ) : 113-9.
  • 10Sato H, Ishihara S, Kawashima K,et al. Expression of peroxisome prolif- erator-activated receptor (PPAR3,) in gastric cancer and inhibitory effects of PPARγ agonists[J]. Br J Cancer,2000;83(10) :1394.

二级参考文献11

  • 1Yoshizawa K,Cioca DP,Kawa S,et al.Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.Cancer,2002;95(10):2243-2251.
  • 2Yoshida K,Tauabe K,Fujii D,et al.Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.Anticancer Res,2003;23(1A):267-273.
  • 3Kitamura S,Miyazaki Y,Shinomura Y,et al.Peroxisome proliferator activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.Jpn J Res,1999;90(1):75-80.
  • 4Itami A,Watanabe G,Shimada Y,et al.Ligands for peroxisome proliferator activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.Int J cancer,2001;94(3):370-376.
  • 5Kim EJ,Park KS,Chung SY,et al.Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostagland in J2 inhibits neuroblastoma cell growth through induction of apoptosis:association with extracellular signal-regulated kinase signal pathway.J Pharmacology & Experimental Therapeutics,2003;307(2):505-517.
  • 6Han C,Demetris AJ,Michalopoulos GK,et al.PPAR-γ ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21WAF1/Cip1 pathway.Hepatology,2003;38(1):167-177.
  • 7Agarwal ML,Agarwal A,Taylor WR,et al.p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.Proc Natl Acad Sci USA,1995;92(18):8493-8497.
  • 8Taylor WR,Stark GR.Regulation of the G2/M transition by p53.Oncogene,2001;20(15):1803-1815.
  • 9Wang XW,Zhan Q,Coursen JD,et al.GADD45 induction of a G2/M cell cycle checkpoint.Proc Natl Acad Sci USA,1999;96(7):3706-3711.
  • 10Yi YW,Kim D,Jung N,et al.Gadd45 family proteins are coactivators of nuclear hormone receptors.Biochem Biophys Res Commun,2000;272(1):193-198.

共引文献9

同被引文献19

  • 1Feng-guangYANG,Zhi-wenZHANG,Dian-qiXIN,Chang-jinSHI,Jie-pingWU,Ying-luGUO,You-feiGUAN.Peroxisome proliferator-activated receptor γ ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines[J].Acta Pharmacologica Sinica,2005,26(6):753-761. 被引量:22
  • 2何晓燕,张敏,陈智超,游泳,田蕾,邹萍.PPAR-γ在肺癌中的表达及在肺癌凋亡中的作用研究[J].中国肺癌杂志,2006,9(1):35-39. 被引量:13
  • 3程文,程南生,熊先泽,夏庆杰,陈清英,闫乃红,敬静.PPAR-γ在肝门部胆管癌中的表达及其配体激活后对胆管癌细胞的作用[J].四川大学学报(医学版),2006,37(5):745-749. 被引量:4
  • 4Perza MA, Burdick AD, Marin HE, et al. The toxicology of ligands for perxisome proliferator - activated receptors (PPAR) [ J]. Toxicol Sci ,2006,90(2) :269 - 295.
  • 5Hwang S J, Kang H J, Song J J, et al. Up - regulation of perox- idase proliferator- activated receptor gamma in cholesteato- ma [ J ]. Laryngoscope, 2006,116 ( 1 ) : 58 - 61.
  • 6Gasparini G, Inelmen EM, Enzi G, et al. Clinical and prog- nostic aspects of gastric carcinoma in the elderly[ J]. J Gas- trointest Surg,2006,10 (3) : 395 - 401.
  • 7Nakajima A, Tomimoto A, Fujita K, et al. Inhibition of per- oxisome proliferator - activated receptor gamma activity sup- presses pancreatic cancer cell motility [ J ]. Cancer Sci, 2008,99(10) : 1892 - 1900.
  • 8Keshamouni VG, Reddy RC, Arenberg DA, et al. Peroxi- some proliferator - activated receptor - ",/ activation inhib- its tumor progression in non -small cell lung cancer[ J]. Oncogene, 2004,25 : 100 - 108.
  • 9Elstner E, Williamson EA, Zang C, et al. Novel therapeuticapproach :ligands for PPAR gamma and retinoid receptors induce apoptosis in bcl - 2 - positive human breast cancer cells [ J ]. Breast Cancer Res Treat, 2002,74 ( 2 ) : 155 - 165.
  • 10Sato H, Ishihara S, Kawashima K, et al. Expression of per- oxisome proliferator activated receptor( PPAR )in gastric cancer and inhibitory effects of PPAR/ gonists [ J ]. Br J Cancer,2000,83 ( 10 ) : 1394 - 1400.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部